Neurodivergent people are one of the few groups who can be deprived of our most basic forms of autonomy and privacy just because of who we are.  This includes confinement in institutional settings such as group homes, nursing homes and residential schools, as well as guardianship and court orders for the misleadingly-named “assisted outpatient treatment.”  Most recently, the United States Food and Drug Administration approved Abilify MyCite, an antipsychotic medication that tracks whether a person has taken it or not. Abilify MyCite further threatens the rights of people with psychosocial disabilities by putting us at risk of surveillance and all the consequences likely to follow from that. As is the case with most practices and technologies that restrict disabled people’s rights, nondisabled people are already defending the new medication as being both for neurodivergent people’s own good and for the convenience of their families and caregivers.  But like in … Continue Reading ››